Cargando…
Ki67 for evaluating the prognosis of gastrointestinal stromal tumors: A systematic review and meta-analysis
Overexpression of Ki67 is observed in tumor cells, and it has been suggested to be a marker for cancer prognosis. However, the relationship between Ki67 expression and the risk of recurrence of gastrointestinal stromal tumors (GISTs) remains poorly defined. In the present study, a meta-analysis was...
Autores principales: | Li, Ji, Wang, An-Ran, Chen, Xiao-Dong, Pan, Hong, Li, Shi-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073573/ https://www.ncbi.nlm.nih.gov/pubmed/35527778 http://dx.doi.org/10.3892/ol.2022.13309 |
Ejemplares similares
-
CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013) -
Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022) -
Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: A systematic review and meta-analysis
por: Zhou, Yu, et al.
Publicado: (2017) -
Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors
por: Wang, Hao, et al.
Publicado: (2014) -
Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors
por: KEMMERLING, RALF, et al.
Publicado: (2014)